psoriasis
2024 DF Annual Meeting
The Dermatology Foundation marked the beginning of its year long 60th anniversary celebration at the Annual Meeting of Membership (AMM) on March 10 and the Annual Reception on March 11 in San Diego, “America’s Finest City,” and inaugurated a year-long celebration to commemorate its six decades of evolution, and impact.
Dr. Marlys Fassett Receives the 2024 DF Bristol Myers Squibb Psoriasis Research Award
Marlys Fassett, MD, PhD, has received the 2024 DF Bristol Myers Squibb Psoriasis Research Award (BMSRA) from the Dermatology Foundation. Dr. Fassett is the second recipient of this prestigious award for extraordinary mid-career investigators. The award comes with $100,000 funding each year for three years to support her research into the role the cytokine IL-31…
Remarkable Career Yields Long-term Benefits for Dermatology
In every field of medical science, there are a handful of leaders recognized by their peers as giants. Dr. John Voorhees, MD, FRCP (London), is one such leader. In an illustrious career spanning several decades, Dr. Voorhees has advanced medical knowledge through dermatologic research, developed innovative approaches to psoriasis treatment, taught and mentored dozens of…
Dr. Junko Takeshita Receives First BMS Psoriasis Research Award
Can educational videos reduce disparities in the research and treatment of psoriasis?
The Value of Connection
In the 38 years he has mentored residents, lectured on dermatology, and run a clinical practice, Dr. Goldfarb has advocated the value of human connection with patients and residents. He believes it inspires trust, enables learning, creates a reciprocal environment of care, and is the central element to bring to a lecture hall, a clinical research unit, or a patient clinic.
Updates in Pustular Psoriasis
Pustular psoriasis is a group of inflammatory skin diseases characterized by visible, sterile pustules on inflamed skin. It appears in generalized and localized forms and can occur in patients with or without a history of psoriasis. Pustular psoriasis has distinct genetic risk factors, inflammatory profile, and response to treatment compared to psoriasis. Thus, it may be its own unique disease. PPP is characterized by sterile pustules on the palms and soles. There is no consensus on optimal treatment , although acitretin, methotrexate, and phototherapy are among the more common treatments.
The Diversity of Skin
In March 2022, Dr. Callender received the Dermatology Foundation’s Clark W. Finnerud Award presented to an individual who “most skillfully blends clinical practice with writing and teaching dermatology, thereby serving as a mentor and role model.”
An Advocate for Dermatology
The Distinguished Service Medallion is the highest honor the Foundation confers on a colleague in recognition of exemplary leadership and service to the specialty of dermatology.
2023 DF Annual Meeting
New Orleans is renowned for its music, food, and joie de vivre. And now it can add the Dermatology Foundation’s Annual Meeting of Membership to its roster of attractions. The Big Easy was host to an event where people reconnect, acknowledge the year’s successes, and celebrate the people who have received Foundation support.
New Topical Therapies for Psoriasis and Atopic Dermatitis
Dr. Bhutani presented new topical therapies for psoriasis and atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib.